BridgeBio Pharma, Inc. (BBIO)
NASDAQ · Healthcare
BridgeBio Pharma, Inc. Cash on Hand 2019–2025
BridgeBio Pharma, Inc. annual cash on hand history from 2019 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- BridgeBio Pharma, Inc. cash on hand as of December 31, 2025: 570.1M, a 16.29% decrease year-over-year.
- BridgeBio Pharma, Inc. cash on hand for 2025 were 570.1M, a 16.29% decrease from 2024.
- BridgeBio Pharma, Inc. cash on hand for 2024 were 681.1M, a 81.18% increase from 2023.
- BridgeBio Pharma, Inc. cash on hand for 2023 were 375.9M, a 0.20% decrease from 2022.
- BridgeBio Pharma, Inc. cash on hand for 2022 were 376.7M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| BridgeBio Pharma, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $570 |
| 2024 | $681 |
| 2023 | $376 |
| 2022 | $377 |
| 2021 | $394 |
| 2020 | $356 |
| 2019 | $364 |
BridgeBio Pharma, Inc. Cash on Hand — FAQ
BridgeBio Pharma, Inc. (BBIO) cash on hand over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BBIO's cash on hand history?
The chart and table above show BridgeBio Pharma, Inc.'s cash on hand by year and by quarter, including the growth rate.